000 05872cam a2200421Mi 4500
001 95251
003 ES-MaUEC
005 20230102112654.0
006 m o d
007 cr cnu---unuuu
008 170121s2017 sz o 001 0 eng d
020 _a3319329731
_q(electronic bk.)
020 _a9783319329734
_q(electronic bk.)
020 _z3319329715
020 _z9783319329710
_q(print)
035 _a(OCoLC)969646235
_z(OCoLC)969853599
_z(OCoLC)974650807
_z(OCoLC)981819146
_z(OCoLC)1005822822
_z(OCoLC)1011954005
040 _aEBLCP
_cEBLCP
_dN$T
_dGW5XE
_dOCLCF
_dUAB
_dOCLCQ
_dNJR
_dYDX
_dOCLCO
_dIDEBK
_dUPM
_dIOG
_dOCLCO
_dMERER
_dESU
_dZ5A
_dOCLCO
_dOCLCQ
_dOHS
_dOCLCO
_dJBG
_dIAD
_dOCLCO
_dICW
_dOCLCO
_dICN
_dOCLCQ
_dOCLCO
_dOTZ
_dOCLCQ
_dVT2
_dOCLCO
_dOCLCQ
_dU3W
_dES-MaUEC
_bspa
050 4 _aR1
_b2017 EB
245 0 0 _aPediatric and adolescent oncofertility :
_bbest practices and emerging technologies
_cTeresa K. Woodruff, Yasmin C. Gosiengfiao, editors.
264 1 _aCham
_bSpringer International Publishing
_c2017
300 _a1 recurso en línea (304 páginas)
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aPreface; Contents; Contributors; Chapter 1: Fertility Risk with Cancer Therapy; Introduction; Estimating Risk; Males; Females; Minimizing Risk; Gonadotropin-Releasing Hormone Agonist; Imatinib; Bone Marrow-Derived Mesenchymal Stem Cells; Sphingosine-1-phosphate (S1P); Tamoxifen; AS101; Granulocyte Colony-Stimulating Factor (G-CSF); Conclusion; References; Chapter 2: Fertility Preservation Options for Female Pediatric and Adolescent Oncology Patients; Introduction; Protection of Ovarian Function; Ovarian Transposition; Ovarian Suppression; Assisted Reproductive Endocrinology.
505 8 _aCombined Hormonal Contraception (Pill, Patch, Ring) Levonorgestrel IUD for Menstrual Suppression; Appendix: Medical Eligibility Criteria for Contraceptive Use; References; Chapter 5: Female Sexual Function in Childhood, Adolescent, and Young Adult Cancer Survivors; Scope of the Problem; Barriers to Care; Sexual Development; Infancy and Childhood; Preadolescence; Adolescence; Sexual Development in Survivors of Childhood Cancer; Risk Factors for Sexual Dysfunction; Long-Term and Late Effects of Cancer Treatment on Sexual Functioning; Physiologic Effects; Psychosocial Effects.
505 8 _aEmbryo and Oocyte Cryopreservation Ovarian Tissue Cryopreservation and Transplantation; Assessment of Ovarian Reserve; Reproductive Options Post Therapy; Donor Oocytes and Embryos; Fertility Preservation Post Therapy; Gestational Carrier; Adoption; Access to Fertility Preservation; Ethical Considerations; Future Directions; Generation of Gametes from Somatic Cells; Coverage of Fertility Preservation by Insurance; Conclusion; References; Chapter 3: Assessing Ovarian Reserve; Background; Assessing Ovarian Reserve; Menstrual Cycles; Antral Follicle Counts and Ovarian Volume.
505 8 _aEndocrine Hormones Follicle-Stimulating Hormone (FSH), Inhibin B, and Estradiol; Anti-Mullerian Hormone (AMH); Current Data on AMH in Children Receiving Cancer Therapy; Ovarian Reserve Testing as a Predictor of Menstrual Pattern and Fertility; Effect of Female Hormones on Ovarian Reserve Testing; References; Chapter 4: Contraception and Menstrual Suppression for Adolescent and Young Adult Oncology Patients; Contraception; Survivors; Menstrual Regulation and Suppression; GnRH Agonist; Progestin-Only Pills; Depot Medroxyprogesterone Acetate.
505 8 _aSocial Effects Female Sexual Dysfunction; Female Sexual Interest/Arousal Disorder (FSIAD); Female Orgasmic Disorder; Genito-pelvic Pain/Penetration Disorder (GPPPD); Screening and Assessment; Treatment; Education and Setting of Expectations; Non-pharmacologic Therapies; Pharmacologic Therapies; When to Refer; Conclusion; References; Chapter 6: Vitrification of Ovarian Tissue for Fertility Preservation; Introduction; Vitrification: Facts and Fallacies; Development of Ovarian Tissue Vitrification Based on Cryobiological Principles; Endpoints of Vitrification Success.
520 3 _aReflecting the increasing interest in fertility management for pediatric and adolescent patients and fulfilling an urgent need to have a comprehensive guide to the management of these individuals, this is the first book of its kind to present a comprehensive discussion of pediatric and adolescent oncofertility. It carefully examines the impact of pediatric cancer and cancer therapy on fertility and presents both current and emerging fertility preservation techniques for both males and females, such as cryopreservation. Fertility concerns beyond cancer are also discussed, including disorders of sexual differentiation, gender dysphoria and thalassemia. Practical chapters on pediatric oncofertility in the clinic round out the book, covering setting up a practice, counseling and consent, disclosure and insurance considerations. Concluding chapters document fertility preservation techniques and outcomes internationally, with contributions from Portuguese, Brazilian and Japanese authors. Timely and wide-ranging, Pediatric and Adolescent Oncofertility is an ideal resource for reproductive medicine specialists, pediatric oncologists, and primary care physicians treating pediatric and adolescent cancer patients looking to protect fertility options.
650 7 _aCáncer en niños
_2embne
_0(OCoLC)fst00845581
_0
_9157453
700 1 _aGosiengfiao, Yasmin C.
700 1 _aWoodruff, Teresa K.
_988137
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-32973-4
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
988 _aSpringer_Medicine_2017
998 _b02/2018
_dz
_e-
_zSI
999 _c95251
_d95251
_x1